BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9169468)

  • 1. Regulation of human apolipoprotein A-I gene expression by gramoxone.
    Cuthbert C; Wang Z; Zhang X; Tam SP
    J Biol Chem; 1997 Jun; 272(23):14954-60. PubMed ID: 9169468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
    Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
    J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
    Zhang X; Chen ZQ; Wang Z; Mohan W; Tam SP
    J Biol Chem; 1996 Oct; 271(43):27152-60. PubMed ID: 8900208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing.
    Harnish DC; Evans MJ; Scicchitano MS; Bhat RA; Karathanasis SK
    J Biol Chem; 1998 Apr; 273(15):9270-8. PubMed ID: 9535920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human apolipoprotein A-I gene expression by equine estrogens.
    Zhang X; Jiao JJ; Bhavnani BR; Tam SP
    J Lipid Res; 2001 Nov; 42(11):1789-800. PubMed ID: 11714848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine.
    Wu JY; Zhang JJ; Wang Y; Reaves SK; Wang YR; Lei PP; Lei KY
    Am J Physiol; 1997 Oct; 273(4):C1362-70. PubMed ID: 9357782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2.
    Horani MH; Gobal F; Haas MJ; Wong NC; Mooradian AD
    Metabolism; 2004 Feb; 53(2):174-81. PubMed ID: 14767868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
    Saladin R; Vu-Dac N; Fruchart JC; Auwerx J; Staels B
    Eur J Biochem; 1996 Jul; 239(2):451-9. PubMed ID: 8706754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.
    Kilbourne EJ; Evans MJ; Karathanasis SK
    Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
    Harnish DC; Malik S; Karathanasis SK
    J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta.
    Haas MJ; Horani M; Mreyoud A; Plummer B; Wong NC; Mooradian AD
    Biochim Biophys Acta; 2003 Oct; 1623(2-3):120-8. PubMed ID: 14572909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional regulatory element of the human ApoA-I gene responsive to a distal enhancer.
    Jones DR; Leffak M
    DNA Cell Biol; 1999 Feb; 18(2):107-19. PubMed ID: 10073570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulatory sequences within the first intron of the chicken apolipoproteinAI (apoAI) gene.
    Bhattacharyya N; Banerjee D
    Gene; 1999 Jul; 234(2):371-80. PubMed ID: 10395911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp and GATA factors are critical for Apolipoprotein AI downstream enhancer activity in human HepG2 cells.
    Ivanov GS; Kater JM; Jha SH; Stutius EA; Sabharwal R; Tricarico MD; Ginsburg GS; Ozer JS
    Gene; 2003 Dec; 323():31-42. PubMed ID: 14659877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
    Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
    J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
    Srivastava RA; Baumann D; Schonfeld G
    Eur J Biochem; 1993 Sep; 216(2):527-38. PubMed ID: 8375391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells.
    Haas MJ; Wong NC; Mooradian AD
    Metabolism; 2004 Jun; 53(6):766-71. PubMed ID: 15164326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
    Srivastava RA
    Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol down-regulates the transcription of microsomal triglyceride transfer protein gene.
    Lin MC; Li JJ; Wang EJ; Princler GL; Kauffman FC; Kung HF
    FASEB J; 1997 Nov; 11(13):1145-52. PubMed ID: 9367349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.